Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
03-22 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
03-22 | Nutra Pharma Corporation Announces Management Changes | CI |
Sales 2020 | 51.9K 71.42K | Sales 2021 | 97.74K 134K | Capitalization | 14.65M 20.16M |
---|---|---|---|---|---|
Net income 2020 | - 0 | Net income 2021 | -13M -17.89M | EV / Sales 2020 | 238 x |
Net Debt 2020 | 5.24M 7.21M | Net Debt 2021 | 8.3M 11.43M | EV / Sales 2021 | 235 x |
P/E ratio 2020 |
-10.3
x | P/E ratio 2021 |
-1.1
x | Employees | 4 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 16-07-26 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Stewart Lonky
BRD | Director/Board Member | 75 | 04-11-04 |
Garry Pottruck
BRD | Director/Board Member | 65 | 09-07-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.0001 | 0.00% | 14 000 |
24-04-26 | 0.0001 | 0.00% | 2,519,500 |
24-04-24 | 0.0001 | 0.00% | 51,094 |
Delayed Quote OTC Markets, May 01, 2024 at 10:50 am
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 706K | |
-0.11% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.65% | 24.63B | |
-23.54% | 18.2B | |
+26.86% | 12.01B | |
-2.85% | 11.76B | |
+14.30% | 10.4B | |
-3.47% | 9.94B |
- Stock Market
- Equities
- NPHC Stock